ISIS Pharmaceuticals announced Friday that the company is changing its name to Ionis Pharmaceuticals.
The California-based biotech company will trade on the Nasdaq under the new ticker symbol “IONS,” replacing “ISIS,” according to CNBC.
The company did not cite the Islamic State of Iraq and Greater Syria, commonly known as ISIS, as the reason for the change in a statement issued by chief operating officer Lynne Parshall.
“Our goal is to create medicines that will save patients’ lives, and we are proud to be at the forefront of creating innovative medicines,” Parshall wrote in a statement. “We decided to change our company name because, when people see or hear our name, we want them to think about the life-saving medicines we are developing.”
More Must-Reads From TIME
- Why We're Spending So Much Money Now
- The Fight to Free Evan Gershkovich
- Meet the 2024 Women of the Year
- John Kerry's Next Move
- The Quiet Work Trees Do for the Planet
- Breaker Sunny Choi Is Heading to Paris
- Column: The Internet Made Romantic Betrayal Even More Devastating
- Want Weekly Recs on What to Watch, Read, and More? Sign Up for Worth Your Time
Contact us at letters@time.com